Item Infomation
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lin, Yi-Wen | - |
| dc.contributor.author | Fang, Chih-Hsiang | - |
| dc.contributor.author | Liang, Ya-Jyun | - |
| dc.date.accessioned | 2023-10-09T08:36:13Z | - |
| dc.date.available | 2023-10-09T08:36:13Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s40824-023-00432-4 | - |
| dc.identifier.uri | https://dlib.phenikaa-uni.edu.vn/handle/PNK/9514 | - |
| dc.description | Cc-BY | vi |
| dc.description.abstract | Alzheimer’s disease is a neurodegenerative disorder, and Aβ aggregation is considered to be the central process implicated in its pathogenesis. Current treatments are faced by challenges such as serious side effects and reduced drug bioavailability. In this study, we developed a drug delivery system for intramuscular injection that uses cellular activity to achieve constant and long-term drug release. | vi |
| dc.language.iso | en | vi |
| dc.publisher | Springer | vi |
| dc.subject | Alzheimer’s disease | vi |
| dc.subject | Controlled release of Clenbuterol | vi |
| dc.title | Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer’s Disease | vi |
| dc.type | Book | vi |
| Appears in Collections | ||
| OER - Khoa học Vật liệu, Ứng dụng | ||
Files in This Item:
